InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Levine Mark S., Dirigeant. Officer active across 2 companies, notably Flexion Therapeutics Inc. In total, 6 disclosures have been recorded. Total volume traded: €43k. The latest transaction was disclosed on 28 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
0143,000 shares0
Common Stock
SEC:0001764013-22-000027·
0143,000 shares0
Common Stock
SEC:0001764013-22-000027:0·
€998,056133,486 shares@ €7.476997.9% of flow
Common Stock
SEC:0001209191-21-065712·
€998,056133,486 shares@ €7.476948.9% of flow
Common Stock
SEC:0001209191-21-065712:0·
€21,5753,945 shares@ €5.4692.1% of flow
Common Stock
SEC:0001209191-21-047502·
€21,5753,945 shares@ €5.4691.1% of flow
Common Stock
SEC:0001209191-21-047502:0·
6 of 6 declarations
About Levine Mark S.
Mark S. Levine is General Counsel and Chief Legal Officer at Flexion Therapeutics Inc and Immunovant, Inc. He oversees the legal affairs of the companies and ensures compliance with applicable regulations.
